A Wisconsin startup is hoping that its disruptive technology will alter the landscape of osteoarthritis treatment forever. Currently, osteoarthritis, especially in the knee, is often treated with hyaluronic acid-based injectable viscosupplements that are meant to alleviate pain and boost joint movement. But Madison, Wisconsin-based Flex Biomedical has developed a polymer-based synthetic viscosupplement that co-founder and […]
Madison-based Echometrix expects to offer EchoSoft, software to improve ultrasound diagnosis and management of tendon and ligament injuries, by year's end, said CEO Sam Adams. Last week, the four-year-old startup filed Securities and Exchange Commission documents seeking to raise $1 million toward that goal.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Mithridion treatments focus on Alzheimer's disease and schizophrenia. Now it might consider treating progressive supranuclear palsy or a type of early onset Alzheimer's disease. Mithridion, based in Madison, Wisconsin, said Tuesday it closed on $1.25 million from Venture Investors, The State of Wisconsin Investment Board and Rocket Ventures.
The U.S. Food and Drug Administration in late October granted a 510(k) marketing clearance for NeuWave's Certus 140TM 2.45 GHz Ablation System. The device attacks tumors with microwave energy in a way that cuts treatment times.
The medical device company from Madison, Wisconsin, said in June it expected to make $1 million this year, and would raise $750,000 to put toward future growth. The company raised $875,000, according to a recent regulatory filing.
The Securities & Exchange Commission charges Brett Cohen and David Meyers in an alleged insider trading scheme involving shares of Exact Sciences Corp. and Sequenom Inc. that netted more than $600,000. The federal Securities & Exchange Commission charged a Baltimore business consultant and his uncle in Cleveland of an insider trading scheme that netted the […]
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Madison, Wisconsin, biotechnology company Quincy Bioscience has received an undisclosed "capital infusion" from DaneVest Tech Fund I, an investment group in its hometown. Quincy will used the money to support national sales of its Prevagen Brain Cell Protection dietary supplements, which are supposed to combat memory loss.
Though it’s yet to even get its brain cell protection drug into Phase 1 trials, Quincy Bioscience is far from the typical young biotech on a shoestring budget. For one thing, there’s the Madison, Wisconsin company’s unusual technology. Quincy has patented the use of a jellyfish protein called aequorin to treat disorders that result from […]
Ever heard of the I-Q Corridor? Unless you’re an economic development geek, probably not. The concept, first penned in a little-noticed Wisconsin Technology Council white paper, envisions an economic superhighway of sorts connecting the Twin Cities, Madison, Wis. and Chicago along interstates 90 and 94. The “I” stands for ideas, innovation, investment, intellectual property while […]
ConjuGon Inc. has raised $1.9 million in equity to develop drugs that combat bacterial infections, according to a Securities and Exchange Commission filing. The fundraise comes from three investors and is part of an offering that the company hopes will bring in $4.75 million. Late last month, the Food and Drug Administration cleared ConjuGon’s Investigational […]
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
Fresh off a $3 million fundraise, Stratatech Corp. plans to begin Phase 2b clinical trials of its genetically engineered human-skin substitute. The Madison, Wis.-based company said it plans to begin the trials of its StrataGraft skin substitute, which is designed for patients suffering from burns or other sever wounds, in the second half of this […]
Ending months of silence, Cellular Dynamics International Inc. is finally talking about its nearly $41 million fund-raise that it says makes it the highest-funded player in the stem cells industry. The company will use the $40.6 million infusion of capital to boost production of its stem-cell derived beating heart cells, the company’s first commercial product, […]
Stratatech Corp. has raised $3 million to continue developing a genetically engineered human skin substitute, according to a regulatory filing. The fundraise comes in the form of debt, options, warrants or other securities, the document filed with the Securities and Exchange Commission said. Robert Barnard, a company official, declined comment on the funding. The company’s […]
Radiopharmaceuticals company Cellectar Inc. has enrolled the last of eight patients in a Phase 1 trial of its cancer-treating drug candidate. The trial is designed to measure drug safety and dosimetry of Cellectar’s lead compound, called CLR1404. Dosimetry refers to the measurement of doses, which also allows investigators to understand how a drug will affect […]